Metropolis Healthcare's Hitech Diagnostics Acquisition To Boost South India Presence: ICICI Securities
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Securities Report
Metropolis Healthcare Ltd. has announced its acquisition of 100% stake in Dr. SP Ganesan’s Hitech Diagnostic Centre (Hitech) in a cash+stock deal.
Hitech is a leading player in South India (primarily Chennai and Bengaluru) with a network of 31 labs and 68 collection centers.
This acquisition will help Metropolis in strengthening presence in South India, improving B2C contribution as Hitech has higher B2C proportion in revenue and in driving potential cost synergies in coming years.
Metropolis will pay a cash consideration of Rs 5.1 billion and will also issue 4,95,000 equity shares for 100% ownership.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.